Drugs for Treatment of Heart Failure Lecture PDF Flashcards
8=D
Types of heart lesions that can facilitate the vicious cycle of heart failure (5)
- ischemia
- infarction
- myopathy
- hypertension
- valve disease
Vicious cycle of heart failure mech of action
- Cardiac lesion decreases cardiac performance
- Baroreceptor fails to be stimulated resulting in increased sympathetic response
- vasomotor response to constrict to increase pressure to perfuse various organs of the body
- Kidney’s juxtaglomerular cells activates RAAS system which causes vasoconstriction and fluid retention (aldosterone)
- workload of heart is increased (afterload and preload)
- increased workload causes myocardial cell structural damage
- further impaired decreased cardiac performance dropping cardiac output even more
- this stimulates causes failure to stimulate baroreceptors….
Drug classes for management of heart failure (4)
- B blockers
- ACE inhibitors
- aldosterone antagonists
- diuretics
2 natriuretic peptides released by heart and their function
1) Atral natriuretic peptide - released in response to increased stretching of atrium to promote loss of Na+ and H2O into urine
2) B natriuretic peptide - Released in response to increases stretching of ventricles and promote arterial and venous dilation and increase GFR to kidney resulting in decreased systemic resistance and loss of Na+ and H2O in urine
Natriuretic peptides are beneficial in ____
diagnosis of heart failure
Why are ACEI preferred to ARB’s in HF
ACEI increase levels of bradykinin which also help in vasodilation and reducing pressure making them HIGHLY efficacious agents, despite the side effect of cough
Drug treatment clinical outcomes in patients with heart failure with preserved ejection fraction
-little evidence it improves clinical outcomes beyond relief
3 routine therapies for heart failure and how they impact the condition
- diuretics (decrease preload, afterload, pulmonary edema, cardiac distension)
- RAAS inhibitors (promote dilation of artereioles and veins and decrease aldosterone release)
- B blockers (not understood mechanism)
DOC for patients with severe heart failure and why
Loop diuretics (furosemide), promote strong diuresis and work even when GFR is low
Unless contraindicated, all patients with HFrEF should receive what drug class for treatment?
ACEI
3 major benefits of ARB’s
- promote dilation of arterioles
- promote dilation of veins
- decrease release of aldosterone
ARB’s 4 effects in heart failure, but why are they not preferred?
- improve LV ejection fraction
- reduce heart failure symptoms
- increase exercise tolerance
- reduce mortality
Do not increase kinin levels having less favorable impact on cardiac remodeling than ACEI
sacubitril/valsartan (entresto) drug class, function, and mech of action
- Angiotensin receptor neprilysin inhibitor (ARNI)
- approved for patients with class II-IV HF to be used in place of an ACEI or ARB as it is superior than elanapril alone when looking at reduced risk of CV related death
- functionally increases natriuretic peptide levels by inhibiting neprilysin that breaks them down
sacubitril/valsartan (entresto) ADR’s (4)
- hypotension by volume depletion
- cough
- hyperkalemia
- fetal harm
Aliskiren (tekturna) function
Can shut down RAAS by binding renin, should work as well as ACEI and ARB’s but is only approved for HTN and not for treatment of HF (doesn’t improve outcomes)
Aldosterone antagonists functions (2) and two examples
- Block receptors for aldosterone in heart and blood vessels, can prevent myocardial remodeling and delay fibrosis (aldosterone increases fibrosis of myocardium and vascular) (as well as its original function to prevent Na+ and thus H2O retention with K+ excretion)
- spironolactone and eplerenone
To avoid the endocrine effects of spironolactone, it is preferable to use the equivalent…
…eplerenone (inspra)